Bio-Thera Secures FDA Approval For Sandoz-Partnered Bevacizumab Biosimilar

Avzivi Is The Second Bio-Thera Biosimilar – And The Second Chinese Biosimilar – To Secure FDA Approval

 
• By Chloe Kent
  
Hands emblazoned with US and China flags about to shake
Bio-Thera has developed both biosimilars researched, developed and manufactured by a Chinese company to recieve US FDA approval • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Products

More from Generics Bulletin